See also this year's filing and all EDGAR filings for this company.
PDF Report 0000792977_2013_AMAG_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'} |
Graph
Absolute values for 0000792977, AMAG Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 254,380,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,297,000 |
| 3 | remainder_Assets | 460,000 |
| 4 | LiabilitiesCurrent | 32,957,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 52,383,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 53,071,000 |
| 9 | ResearchAndDevelopmentExpense | 33,296,000 |
| 10 | remainder_Expenses | 16,435,000 |
| 11 | remainder_Revenues | 85,378,000 |
| 12 | remainder_NetIncome | -180,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 258,137,000 |
| 1 | Liabilities | 85,340,000 |
| 2 | Expenses | 102,802,000 |
| 3 | Revenues | 85,378,000 |
| 4 | StockholdersEquity | 172,797,000 |
| 5 | NetIncome | -17,604,000 |
| 6 | ComprehensiveNetIncome | -17,604,000 |
| 7 | BaseVar | 265,918,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.09 |
| 9 | EconomicCapitalRatio | 3.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
